Investors

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Jan 10, 2012 terifay robert j Officer Option Execute 20,000 21.34 - 21.92
Nov 21, 2012 terifay robert j Officer Option Execute 20,000 16.80
Aug 26, 2014 tessier-lavigne marc Director Option Execute 1,387 50.91
Aug 27, 2014 tessier-lavigne marc Director Option Execute 3,000 50.91
May 6, 2013 tessier-lavigne marc Director Option Execute 13,334 50.91 - 57.11
Feb 26, 2015 tessier-lavigne marc Director Option Execute 3,000 50.91
Dec 8, 2009 vagelos p roy Director Option Execute 187,500 8.77
Dec 19, 2008 vagelos p roy Director Option Execute 130,000 7.41
Feb 27, 2008 vagelos p roy Director Option Execute 6,666 7.91
Aug 26, 2014 vagelos p roy Officer Option Execute 303,909 11.64
Aug 7, 2014 vagelos p roy Officer Option Execute 270,352 9.49
Feb 27, 2014 vagelos p roy Officer Option Execute 70,879 9.49 - 21.92
Nov 23, 2012 vagelos p roy Officer Option Execute 312,500 19.43
Sep 18, 2013 vagelos p roy Officer Option Execute 312,500 13.00
Aug 31, 2011 vagelos p roy Officer Option Execute 312,500 28.01
Dec 20, 2012 van plew daniel p Officer Option Execute 2,050 16.80
May 6, 2013 van plew daniel p Officer Option Execute 32,950 16.80
Oct 25, 2012 van plew daniel p Officer Option Execute 30,000 21.92
Sep 17, 2013 van plew daniel p Officer Option Execute 52,500 16.80
Apr 27, 2012 van plew daniel p Officer Option Execute 35,216 20.90
Showing 361-380 of 950 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)